Mehta Biotech Capital: Week 19 Update

Trading and Markets
1

You can learn more about Mehta Biotech Capital here: https://collective2.com/details/966078539

It was yet another great week for Mehta Biotech Capital, as Oramed Pharmaceuticals (NASDAQ:ORMP) closed a license and investment deal with Hefei Tianhui Incubation of Technologies (HTIT) of China.

Oramed has sold 1,155,367 restricted common shares to HTIT at a price of $10.39 each, or a total of $12-million. Oramed also has received regulatory approval in Israel, and closed, an out-licensing agreement with HTIT for its lead oral insulin capsule, ORMD-0801.

Under the terms of the accord, HTIT has exclusive rights to commercialize ORMD-0801 in Greater China in return for multiple milestone payments totaling $38-million and up to a 10% royalty, based on net sales of the product in China.

“We regard the closing of these transactions as a huge achievement and we now look forward towards our continued collaboration with the creative and experienced team at HTIT,” Oramed CEO, Nadav Kidron, said in a statement.

Mehta Biotech Capital continues to monitor developments in this company for trading opportunities. We remain confident that the pending catalysts will bear even more fruit for our subscribers.

You can learn more about Mehta Biotech Capital here: https://collective2.com/details/966078539

2

How did you manage to get 10,000 shares of SCNG @ $0.00?

“It was yet another great week for Mehta Biotech Capital”

Do you care to talk about how your system will benefit any subscriber when the trades you take are impossible? You speak about how the system is doing great? You are simply taking advantage of large bid/ask spreads where maybe 1 share trades every day at ask/bid. There is no way you can fill 10,000 shares @ $0.00 and sell it 7 minutes later @ $0.45.

1 Like
3

Yahoo shows that only 100 shares of SCNG were traded on that day. Probably these shares were traded at 0.45. By the way it is not the first questionable trade in this system. Looks like C2 doesn’t verify volumes, only prices and this bug/loophole is used here. My question to the system developer about volumes still remains unanswered.

2 Likes